Covered recipient · General Payments record
DANIEL MARKMANN
General Payments · PY2018–2022
$2,470.65
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $579.97 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sientra, Inc. | $409.58 | 5 |
| Galderma Laboratories, L.P. | $82.43 | 4 |
| Avanos Medical | $48.16 | 1 |
| Teleflex LLC | $39.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Avanos Medical | $48.16 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946596997 | CMS |
| Galderma Laboratories, L.P. | $15.34 | 03/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952285075 | CMS |
| Galderma Laboratories, L.P. | $23.69 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952285077 | CMS |
| Galderma Laboratories, L.P. | $22.08 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952285079 | CMS |
| Galderma Laboratories, L.P. | $21.32 | 11/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952285081 | CMS |
| Sientra, Inc. | $31.00 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960406499 | CMS |
| Sientra, Inc. | $25.80 | 02/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960406497 | CMS |
| Sientra, Inc. | $40.33 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960406501 | CMS |
| Sientra, Inc. | $19.20 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960406495 | CMS |
| Sientra, Inc. | $293.25 | 09/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960406503 | CMS |
| Teleflex LLC | $39.80 | 11/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929159405 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.